Our News on Newswise

Newswise: 6699354922de5_DSF4462.jpg

Study finds persistent proteins may influence metabolomics results

Van Andel Institute scientists have identified more than 1,000 previously undetected proteins in common metabolite samples, which persist despite extraction methods designed to weed them out.
18-Jul-2024 11:40 AM EDT Add to Favorites

Heating proteins to body temperature reveals new drug targets

Some proteins shift their shape when exposed to different temperatures, revealing previously unknown binding sites for medications.
15-May-2024 12:05 PM EDT Add to Favorites

Newswise: 661ebab3b6727_FeaturedImageSuggestion2.png

Scientists identify cell vulnerability ‘fingerprint’ related to Parkinson’s, Lewy body dementia

A new study offers a first look into the complex molecular changes that occur in brain cells with Lewy bodies, which are key pathological hallmarks of Parkinson’s disease and some dementias.
16-Apr-2024 2:05 PM EDT Add to Favorites

Newswise: 6604546407ddb_RothbartSciAdvArtHedVanAndelInstitute.png

Combining Epigenetic Cancer Medications May Have Benefit for Colorectal Cancers and Other Tumor Types

A pair of medications that make malignant cells act as if they have a virus could hold new promise for treating colorectal cancers and other solid tumors, reports a study published today in Science Advances.
27-Mar-2024 1:30 PM EDT Add to Favorites

Newswise: 6553a076d8e51_ARTHEDMolPsych1500x600.png

Inflammation and loss of protective mechanisms in the brain linked to suicide risk

A first-of-its-kind study has identified overactive inflammation and loss of critical protection mechanisms in the brain as potential contributors to suicide risk.
14-Nov-2023 11:05 AM EST Add to Favorites

Newswise: 651c206e9b45d_Dr.NickBurtonCourtesyofVanAndelInstitute.jpg

Van Andel Institute scientist awarded $2.9 million to tackle insulin resistance, a driver of Type 2 diabetes

Nick Burton, Ph.D., has earned a five-year, nearly $2.9 million New Innovator Award from the National Institutes of Health Common Fund to find new ways to fix or prevent insulin resistance, a key driver of Type 2 diabetes.
3-Oct-2023 10:05 AM EDT Add to Favorites

Newswise: 6515b3a356358_Dr.PeterA.JonesCourtesyofVanAndelInstitute.jpg

Van Andel Institute chief scientist earns $7.9 million Outstanding Investigator Award to support cancer research

Van Andel Institute Chief Scientific Officer Peter A. Jones, Ph.D., D.Sc. (hon), has received a seven-year, nearly $7.9 million grant from the National Cancer Institute’s Outstanding Investigator Award program.
28-Sep-2023 1:05 PM EDT Add to Favorites

Newswise: 65131fbe0cca9_Dr.EricSwindellCourtesyofVanAndelInstitute.jpg

Van Andel Institute appoints new Graduate School dean and chief academic officer

Van Andel Institute has appointed Eric Swindell, Ph.D., as dean and chief academic officer of Van Andel Institute Graduate School, effective Dec. 4, 2023.
26-Sep-2023 4:05 PM EDT Add to Favorites


See All News

Our Experts on Newswise

COVID-19 infection may be part of a ‘perfect storm’ for Parkinson’s disease

GRAND RAPIDS, Mich. (Oct. 22, 2020) — Can COVID-19 infection increase the risk of developing Parkinson’s disease?
22-Oct-2020 1:00 PM EDT

Van Andel Research Institute Expands Into New Areas of Parkinson’s Research

Van Andel Research Institute (VARI) is continuing the expansion of its neurodegenerative disease research program, which aims to answer fundamental questions about diseases such as Parkinson’s and Alzheimer’s, with the addition of two...
16-Nov-2015 1:00 PM EST

See All Experts

Our YouTube Videos

About

Van Andel Institute (VAI) is an independent biomedical research and science education organization committed to improving the health and enhancing the lives of current and future generations. Established by Jay and Betty Van Andel in 1996 in Grand Rapids, Michigan, VAI has grown into a premiere research and educational institution that supports the work of more than 350 scientists, educators and staff.

Experts

Twitter

close
0.2503